• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/20

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

20 Cards in this Set

  • Front
  • Back

IND?

Investigational New Drug


Notice of Claimed Investigational Exemption of a New Drug



Must be approved by FDA before clinical trials begin

Does the FDA have the ability to block the testing of a new drug?

yes, it can block it at the request for IND

Phase 1 of clinical trials?


• Pilot study in 20-80 healthy volunteers
• Determination of safety of several doses
• Determination of pharmacokinetic properties
Non-blinded
• About 20% of tested drugs are approved

Phase 2 clinical trials?

• Studies in 100-200 patients with target disease
• Placebo and active drug controls
• Single-blind
• About 30% of tested drugs are approved

Phase 3 clinical trials?

• Studies in many (about 5000) patients with target disease
• Determination of efficacy for indication and side effects
• Usually double-blind and cross-over design with placebo or active control
• About 70% of tested drugs are approved



The only phase where the majority are approved

What comes after phase 3?

New Drug Application

What is "the label?"

• Approved by FDA as part of NDA process
• Same as package insert
• Available in The Physician’s Desk Reference
• Contains chemistry, pk, indication, side effects, toxicity, contraindications, dosage, information in special populations
• NOT a critical guide; doesn't compare it to other drugs on market

Phase 4?

Post-marketing surveillance

Can you ship a drug for an indication other than it's "label?"



Can you prescribe one?

-can't ship one



-CAN prescribe one to individual pt

Generic manufacturer must prove bioequivalence of generic formulation within ______% of the proprietary formulation

+/- 20%

Treatment IND (1987) = Promising investigational drugs in what phase can be available for patients with life-threatening conditions or serious chronic conditions?

late Phase II or III

Regulatory authority of prescriptions?

state boards

Schedule 1 drug definition?


high abuse potential


Unsafe


research only


no accepted medical use


Examples of schedule 1 drugs

heroin


Marijuana (but not really)

Schedule 2 drug definition

severe physical/psychological dependence


WRITTEN prescription required


no refills

examples of schedule 2 drug?

morphine


amphetamine

schedule 3 drug definition?

moderate-to-low physical dependence


high psychological dependence


written or oral prescriptions - no more than 5 refills

Examples of schedule 3 drug?

Codeine

Schedule 4 drug definition? Examples?

Same as schedule 3 but penalties for illegal possession are different



benzodiazepines

Schedule 5? examples?

over the counter stuff



antitussives with low codeine